SMTL ID : 7l3n.1

SARS-CoV 2 Spike Protein bound to LY-CoV555

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-1-1-mer

Ligands

3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: N.705, T.707, L.910, Q.914, Q.1059 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 4 residues within 4Å: Chain C: N.705, L.910, Q.914, Q.1059 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 3 residues within 4Å: Chain C: N.789, S.791, Q.792 No protein-ligand interaction detected (PLIP)

16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 4 residues within 4Å: Chain A: S.696, N.697, N.698 Chain B: D.784 Ligand excluded by PLIP NAG.5: 3 residues within 4Å: Chain A: N.789, S.791, Q.792 Ligand excluded by PLIP NAG.6: 2 residues within 4Å: Chain A: A.694, N.1062 Ligand excluded by PLIP NAG.7: 3 residues within 4Å: Chain A: N.1086, T.1088, F.1091 Ligand excluded by PLIP NAG.8: 1 residues within 4Å: Chain A: N.1122 Ligand excluded by PLIP NAG.9: 3 residues within 4Å: Chain B: A.694, E.1060, N.1062 Ligand excluded by PLIP NAG.10: 3 residues within 4Å: Chain B: F.326, G.327, N.331 Ligand excluded by PLIP NAG.11: 2 residues within 4Å: Chain B: N.604, T.606 Ligand excluded by PLIP NAG.12: 3 residues within 4Å: Chain B: N.697, G.1119 Chain C: D.784 Ligand excluded by PLIP NAG.13: 1 residues within 4Å: Chain B: N.789 Ligand excluded by PLIP NAG.14: 1 residues within 4Å: Chain B: N.1122 Ligand excluded by PLIP NAG.15: 4 residues within 4Å: Chain B: N.705, N.907, L.910, Q.1059 Ligand excluded by PLIP NAG.16: 4 residues within 4Å: Chain A: Q.883 Chain C: A.694, E.1060, N.1062 Ligand excluded by PLIP NAG.17: 4 residues within 4Å: Chain B: K.546 Chain C: N.268, E.269, N.270 Ligand excluded by PLIP NAG.18: 3 residues within 4Å: Chain A: D.784 Chain C: N.697, G.1119 Ligand excluded by PLIP NAG.19: 1 residues within 4Å: Chain C: N.1122 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jones, B.E. et al., LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection. Biorxiv (2020)

Release Date

2021-02-03

Peptides

Spike glycoprotein: ABC
LY-CoV555 Fab heavy chain: D
LY-CoV555 Fab light chain: E

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

Spike glycoprotein

LY-CoV555 Fab heavy chain

LY-CoV555 Fab light chain

Related Entries With Identical Sequence